Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Longstanding fears that using mobile phones may increase the risk of developing a brain tumour have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage.

Lots of people around a table each holding a mobile phone

Since mobile phones are held close to the head, the radiofrequency waves they emit penetrate several centimetres into the brain, with the temporal and parietal lobes being most exposed. This has led to concern that mobile phone users may be at an increased risk of developing brain tumours, with the International Agency for Research on Cancer (IARC) classifying radiofrequency waves as ‘possibly carcinogenic.’ However, most of the studies that have investigated this question to date have been retrospective studies in which individuals report mobile phone use after a diagnosis of cancer, meaning that the results may be biased.

Today, researchers from Oxford Population Health and IARC have reported the results of a large UK prospective study (a study in which participants are enrolled before they develop the disease(s) in question) to investigate the association between mobile phone use and brain tumour risk. The results are published in the Journal of the National Cancer Institute.

Read the full story on the University of Oxford website

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.